Re: NATIONAL TOXICOLOGY AND DE-TOXICOLOGY CENTER OF EXCELLENCE - don

[Guest guest]

I recommend that you be careful of such an insittute. The pharmaceutical

industry wants to be able to treat individuals with chemical hypersensitivity

with their synthetic drugs. We do not know enough about the illness, which is

also known as MCS and related illnesses (fibromyalgia and CFS) to be developing

protocols for treatment. We do know that there are multiple health problems in

these individuals ranging from immune dysregulation through muscle pain, fatigue

and neurocognitive deficits. There is limited research that indicates genetic

components are involve, e.g. genetic polymorphism in detoxification pathways as

well as HLA complex. Adding synthetic pharmaceuticals to the mixture is not a

good idea. I suggest you check out the National Toxicology and De-Toxicology

Center and find out what or who is funding this group. Jack D. Thrasher, Ph.D.

Toxicologist/Immunotoxicologist/Fetaltoxicologist

www.drthrasher.org